HOME > TOP STORIES
TOP STORIES
-
ORGANIZATION FPMAJ Chief Praises Political Acumen of New LDP Leader Kishida, Seeks Support for Industry
September 30, 2021
-
COMMENTARY 5 Companies Developing Japan-Made COVID-19 Jabs Face Challenges in Subject Enrollment, Trial Designs
September 29, 2021
-
BUSINESS Shionogi Kicks Off Japan PII/III Trial for Oral COVID-19 Drug
September 29, 2021
-
REGULATORY Japan Approves Padcev, Entresto’s Hypertension Use, Lilly’s RET Inhibitor and More
September 28, 2021
-
REGULATORY Japan Approves GSK’s COVID-19 Antibody Drug, 2nd Treatment for Mild Cases
September 28, 2021
-
ORGANIZATION Chuikyo Payer Rep Wants to Cut into Cost-Based Method, Adjustment Rate, Off-Year Revision in FY2022 Reform, Eyes Special Rules for Aducanumab
September 27, 2021
-
BUSINESS Startup Headed by Ex-Biogen Japan Chief Working to Develop New Alzheimer’s Drugs Using Photocatalysts
September 27, 2021
-
REGULATORY One-Month Business Suspension Order Likely for Choseido over Generic Recalls
September 24, 2021
-
BUSINESS Shionogi to Begin PII/III Study for Oral COVID-19 Drug on Sept. 27: President
September 24, 2021
-
BUSINESS Shionogi Gets New Oral COVID-19 Drug into Clinic in Less than 1 Year, Now Gearing Up for PII/III
September 24, 2021
-
ORGANIZATION JPMA Chief Opposes Macroeconomic Indexing, Says Drugs Should Drive Economic Growth
September 22, 2021
-
REGULATORY GSK/Vir’s COVID-19 Drug Up for MHLW Panel Review on Sept. 27
September 22, 2021
-
BUSINESS New Heart Failure Drugs Jostling with Different Modes of Action, Offering Variety of Options
September 21, 2021
-
REGULATORY All 4 Contenders in LDP Leadership Race Vow to Expand COVID-19 Measures
September 21, 2021
-
REGULATORY Japan to Start Discussions in October on Reinstating HPV Vaccine Recommendation
September 21, 2021
-
BUSINESS Sumitomo Dainippon Expects Twymeeg’s Initial Uptake in Combo, but Eyes 1st Line Monotherapy Use Too
September 17, 2021
-
BUSINESS White Matter Found in COVID-19 Vaccine Vials Not Contaminant: Pfizer
September 16, 2021
-
REGULATORY Tainted Moderna Jabs Run Afoul of PMD Law: Minister
September 16, 2021
-
REGULATORY Japan Eyes Legal System to Ensure Generic Supplies in New Industry Vision, Key Official Says It’s Difficult with Companies’ Own Efforts Alone
September 15, 2021
-
REGULATORY Japan Unveils New Pharma Industry Vision, 1st Update in 8 Years
September 14, 2021
ページ
In the complex landscape of the Japanese pharmaceutical market, the “status quo” is often the safest harbor. But for leaders like Kennet Brysting, former president of Gilead Japan, the status quo is the most dangerous place to stay.Innovation in Japan…
